Business Standard

India Coronavirus Dispatch: Top WHO official backs move to approve Covaxin

No free jabs for all in next vaccine phase, virus affects more parts of body than commonly believed, mental health amid pandemic-news relevant to India's fight against Covid-19

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Premium

Bharath Manjesh New Delhi
IN NUMBERS: Over 10,500 fresh cases reported

India reported 10,584 fresh coronavirus infections on Tuesday, taking the cumulative caseload to 11,016,434, according to a report in the Scroll. The country saw 78 deaths due to the pandemic, taking the toll to 156,463, according to central health ministry data. Total recoveries have surged to 10,712,665. The national recovery rate is at 97.24 per cent. The active caseload is at 147,306, or 1.34 per cent of the total caseload. About 11,745,552 healthcare and frontline workers have been inoculated since the nationwide inoculation programme kicked off on January 16, the report said.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in